0001551152 2026-08-06 2026-08-06 0001551152 1 2026-08-06 2026-08-06 0001551152 2 2026-08-06 2026-08-06 0001551152 3 2026-08-06 2026-08-06 0001551152 4 2026-08-06 2026-08-06 0001551152 5 2026-08-06 2026-08-06 0001551152 6 2026-08-06 2026-08-06 0001551152 7 2026-08-06 2026-08-06 0001551152 8 2026-08-06 2026-08-06 0001551152 9 2026-08-06 2026-08-06 iso4217:USD pure shares S-3 424B5 EX-FILING FEES 333-284980 0001551152 AbbVie Inc. N/A N/A S-3 AbbVie Inc. false Debt Senior Floating Rate Notes due 2028 true 500000000 1.00 500000000.00 0.0001381 69050.00 false Debt 4.500% Senior Notes due 2028 true 1000000000 0.9997 999700000.00 0.0001381 138058.57 false Debt 4.650% Senior Notes due 2030 true 1250000000 0.99862 1248275000.00 0.0001381 172386.78 false Debt 4.875% Senior Notes due 2031 true 1500000000 0.99977 1499655000.00 0.0001381 207102.36 false Debt 5.050% Senior Notes due 2033 true 1250000000 0.99889 1248612500.00 0.0001381 172433.39 false Debt 5.300% Senior Notes due 2036 true 1500000000 0.99832 1497480000.00 0.0001381 206801.99 false Debt 5.450% Senior Notes due 2038 true 1000000000 0.9981 998100000.00 0.0001381 137837.61 false Debt 6.000% Senior Notes due 2056 true 1500000000 0.99441 1491615000.00 0.0001381 205992.03 false Debt 6.100% Senior Notes due 2066 true 500000000 0.99843 499215000.00 0.0001381 68941.59 9982652500.00 1378604.32 0.00 0.00 1378604.32 The prospectus supplement to which this Exhibit is attached is a final prospectus for the related offerings. The maximum aggregate amount of those offerings is $10,000,000,000. See Offering Note 1. See Offering Note 1. See Offering Note 1. See Offering Note 1. See Offering Note 1. See Offering Note 1. See Offering Note 1. See Offering Note 1. 9982652500.00 true